How many insider trades does FilingIQ track for TLSI?

FilingIQ tracks 96 Form 4 insider transactions for TLSI (TriSalus Life Sciences, Inc.), covering filings from Aug 10, 2023 onwards. 20 of those were filed in the last 90 days.

Are TLSI insiders net buyers or net sellers?

Across the full Form 4 history for TLSI, 22 transactions (23%) were open-market purchases and 21 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TLSI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TLSI in?

TriSalus Life Sciences, Inc. (TLSI) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $237.33M.

TLSI insider trading

Healthcare

TriSalus Life Sciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

23% / 22%

Market cap

$237.33M

About TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers. It offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. The company was founded in 2009 and is headquartered in Westminster, Colorado.

Company website: trisaluslifesci.com

TLSI insider activity at a glance

FilingIQ has scored 96 insider transactions for TLSI since Aug 10, 2023. The most recent filing in our index is dated Mar 17, 2026.

Across the full history, 22 open-market purchases and 21 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TLSI insider trades is 60.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TLSI trades on FilingIQ Raw filings on SEC EDGAR

Latest TLSI Form 4 filings

Szela Mary T CEO and President

P Feb 23, 2026

Young James Emmett Chief Financial Officer

P Jan 27, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TLSI?: FilingIQ tracks 96 Form 4 insider transactions for TLSI (TriSalus Life Sciences, Inc.), covering filings from Aug 10, 2023 onwards. 20 of those were filed in the last 90 days.
Are TLSI insiders net buyers or net sellers?: Across the full Form 4 history for TLSI, 22 transactions (23%) were open-market purchases and 21 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TLSI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TLSI in?: TriSalus Life Sciences, Inc. (TLSI) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $237.33M.

Methodology & sources

Every TLSI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.